A new-onset atrial fibrillation: The incidence of potassium and magnesium deficiency. The efficacy of intravenous potassium/magnesium supplementation in cardioversion to sinus rhythm;Wysta̧pienie migotania przedsionków: Jak czȩste sa̧ niedobory potasu i magnezu? Efekty potasu i magnezu we wlewie glukozy z insulina̧ w przywracaniu rytmu zatokowego

Kardiologia Polska

Volumn 60, Issue 6, 2004, Pages 578-582

  Cybulski, Jacek ^a   Budaj, Andrzej ^a   Danielewicz, Henryk ^a   Maciejewicz, Janusz ^a   Ceremuzyński, Leszek ^a   Wysokiński, Andrzej ^b  

^a GROCHOWSKI HOSPITAL   (Poland)

^b Medical University of Lublin Katedra i Klinika Kardiologii   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; GLUCOSE; INSULIN; MAGNESIUM SULFATE; POTASSIUM CHLORIDE;

ADULT; AGED; ARTICLE; CARDIOVERSION; DRUG EFFICACY; ELECTROLYTE DISTURBANCE; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; MAGNESIUM DEFICIENCY; MAJOR CLINICAL STUDY; MALE; POTASSIUM DEFICIENCY; SINUS RHYTHM; TREATMENT OUTCOME;

EID: 3042779071     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bialy D., Lehman M.N., Schumbacher D.N. i wsp.: Hospitalization for arrhythmia in the United States. Importance of atrial fibrillation. J. Am. Coll. Cardiol. 1992, 19 (Suppl. A), 41A.
2. Boyden P.A.: Models of atrial reentry. J. Cardiovasc. Electrophysiol. 1995, 6, 313.
3. Gullestad L., Birkeland K., Molstad P. i wsp.: The effect of magnesium versus verapamil on supraventricular arrhythmias. Clin. Cardiol. 1993, 16, 429-434.
4. Brodsky M.A., Orlov M.V., Caparelli E.V. i wsp.: Magnesium therapy in new-onset atrial fibrillation. Am. J. Cardiol. 1994, 73, 1227-1229.
5. Cybulski J., Kułakowski P., Budaj A. i wsp.: Intravenous amiodarone for cardioversion of paroxysmal atrial fibrillation. Clin. Cardiol. 2003, 26, 329-335.
6. De Carli C., Sprouse G., La Rosa J.C.: Serum magnesium levels in symptomatic atrial fibrillation and their relation to rhythm control by intravenous digoxin. Am. J. Cardiol. 1986, 57, 956-959.
7. Singh R.B., Manmohan M.D., Dube K.P. i wsp.: Serum magnesium concentration in atrial fibrillation. Acta Cardiol. 1976, 31, 221-226.
8. Wahr J.A., Parks R., Boisvert D. i wsp.: Preoperative potassium levels and perioperative outcomes in cardiac surgery patients. Multicenter Study of Perioperative Ischemia Research Group. JAMA 1999, 281, 2203-2210.
9. Leier C.V., Dei Cas L., Metra M.: Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: Hyponatremia, hypokalemia and hypomagnesemia. Am. Heart J. 1994, 128, 564-568.
10. Kaplan N.M.: Clinical Hypertension. Williams & Willkins, Baltimore, 1994.
11. Terzi A., Furlan G., Chiavvacci P. i wsp.: Prevention of atrial tachyarrhythmias after non-cardiac thoracic surgery by infusion of magnesium sulphate. Thorac. Cardiovasc. Surg. 1996, 44, 300-303.
12. 4 replacement. J. Card. Surg. 1996, 11, 421-427.